The recent entry of an activist investor draws attention to the potential for Bio-Rad's shares to be re-rated. Read more on ...

Activist investors pushed global companies more aggressively ⁠in ⁠the second quarter to make changes and ⁠lifted the overall ...

Bio-Rad posts robust margins and liquidity, while Charles River leads in global drug discovery services. Explore how their fundamentals stack up for investors.

Complete Bio-Rad Laboratories Inc. Cl B stock information by Barron's. View real-time BUW stock price and news, along with industry-best analysis.

Bio-Rad is a global leader in developing, manufacturing and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and ...

Jonathan DiVincenzo (President & COO) said Bio-Rad “reported Q1 results within our revenue guidance” while facing “several external pressures, most notably associated with the ongoing conflict in the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the letter can be downloaded here. The third quarter was a strong one for the fund ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” first-quarter 2025 investor letter. A copy of the letter can be downloaded here. The growth stock trade ...